COCRYSTAL PHARMA, INC. — Net Income by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/5f7f0c9f-b3b3-4b1d-8f0d-6dc45dc05f4c/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-8.8M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-013838 |
| FY 2024 | $-17.5M | 2024-01-01 – 2024-12-31 | evidence 0001641172-25-001496 |
| FY 2023 | $-18.0M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-011613 |
| FY 2022 | $-38.8M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-009385 |
| FY 2021 | $-14.2M | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-007551 |
| FY 2020 | $-9.6M | 2020-01-01 – 2020-12-31 | evidence 0001493152-21-006211 |
| FY 2019 | $-48.2M | 2019-01-01 – 2019-12-31 | evidence 0001493152-20-004916 |
| FY 2018 | $-49.0M | 2018-01-01 – 2018-12-31 | evidence 0001493152-19-004386 |
| FY 2017 | $-613.0k | 2017-01-01 – 2017-12-31 | evidence 0001493152-18-003708 |
| FY 2016 | $-74.9M | 2016-01-01 – 2016-12-31 | evidence 0001493152-17-003110 |
| FY 2015 | $-50.1M | 2015-01-01 – 2015-12-31 | evidence 0001415889-16-005091 |
| FY 2014 | $-99.0k | 2014-01-01 – 2014-12-31 | evidence 0001415889-15-001157 |
| FY 2013 | $-12.7M | 2007-01-07 – 2014-03-31 | evidence 0001415889-14-001531 |
| FY 2012 | $-8.0M | 2012-01-01 – 2012-12-31 | evidence 0001521536-13-000307 |
| FY 2011 | $-5.5M | 2011-01-01 – 2011-12-31 | evidence 0001521536-12-000282 |
| FY 2010 | $-319.8k | 2010-01-01 – 2010-12-31 | evidence 0001521536-12-000282 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
COCRYSTAL PHARMA, INC. — all facts · Revenue · Operating Income